KAL NADH
Go to StoreServing Size: 1 Tablet | ||
Servings Per Container: 30 | ||
Amount Per Serving | % DV * | |
NADH (reduced B-nicotinamide adenine dinucleotide as the disodium salt) | 5mg | * |
* % Daily Value (DV) is based on a 2,000 calorie diet. Your daily values may be higher or lower based on your calorie needs.
† Daily Value (DV) not established. |
||
Other Ingredients: Cellulose, stearic acid and silica, and glyceryl triacetate (enteric coating) |
||
Directions: As a dietary supplement, adults and children 8 years and older take 1-2 tablets on an empty stomach each morning. Wait about one half hour before eating. Consume with an 8 ounce glass of water. |
Serving Size: 1 Tablet | ||
Servings Per Container: 60 | ||
Amount Per Serving | % DV * | |
NADH (reduced 8-nicotinamide adenine dinucleotide as the disodium salt) | 5mg | * |
* % Daily Value (DV) is based on a 2,000 calorie diet. Your daily values may be higher or lower based on your calorie needs.
† Daily Value (DV) not established. |
||
Other Ingredients: Cellulose, stearic acid, silica and glyceryl triacetate (enteric coating). |
||
Directions: Use only as directed. Adults and children 8 years and older take 1 tablet on an empty stomach each morning. Wait about one half hour before eating. Consume with an 8 oz glass of water. |
KAL NADH
Go to Store- Description
KAL NADH 5mg 60 Tablets
NADH is short for Nicotinamide Adenine Dinucleotide or NAD+. NADH plays a role in energizing your body and is often used by those suffering from fatigue. NADH is also commonly used to improve exercise performance as well as improving mental clarity and alertness. KAL's NADH contains 5mg of NADH per serving.
KAL NADH Product Highlights & Benefits
- Improve Mental Clarity, Alertness, Concentration and Memory
- NADH Plays a Role in Energy Production
- May Help Improve Athletic Performance
- 5mg NADH Per Serving
Directions
Take 1 tablet on an empty stomach each morning with a glass of water.
KAL NADH 5mg 60 Tablets Ingredients & Supplement Facts
Warnings & Side Effects
Store in a cool dry place after opening.
References
Alegre J, Rosés JM, Javierre C, Ruiz-Baqués A, Segundo MJ, de Sevilla TF. Nicotinamida adenina dinucleótido (NADH) en pacientes con síndrome de fatiga crónica [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome]. Rev Clin Esp. 2010 Jun;210(6):284-8. Spanish. doi: 10.1016/j.rce.2009.09.015. Epub 2010 May 5. PMID: 20447621.
https://pubmed.ncbi.nlm.nih.gov/20447621/